FindMyRecallSubscribe
Class I: serious health riskCompleted

Hospira Carboplatin Injection Recall

Carboplatin Injection, 600 mg/60 mL (10 mg/mL), 60 mL, Cytotoxic Agent, Sterile, Multi-…

Hospira Inc. · Lake Forest, IL

Risk level
Class I
Reported by FDA
Feb 13, 2013
Recall ID
D-153-2013
Check your lot numberHow we source this data

Summary

Hospira recalled Carboplatin Injection starting Nov 8, 2012. The FDA classified it as Class I (serious health risk) and published enforcement report D-153-2013 on Feb 13, 2013. Reason: Crystallization: Product is being recalled due to visible particulates identified during a retain sample inspection. Findings have identified the particles as Carboplatin crystals. Status: Completed.

Why it was recalled

Crystallization: Product is being recalled due to visible particulates identified during a retain sample inspection. Findings have identified the particles as Carboplatin crystals.

Product description

Carboplatin Injection, 600 mg/60 mL (10 mg/mL), 60 mL, Cytotoxic Agent, Sterile, Multi-Dose Vial, Rx only, For IV Use, Hospira, Inc., Lake Forest, IL 60045, Product of Australia, NDC 61703-339-56.

Lot numbers, UPCs & expiration codes

Lot #: Z021650AA, Exp. 08/2013

Where it was sold

Nationwide and Puerto Rico.

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-153-2013
Classification
Class I
Status
Completed
Recall initiated
Nov 8, 2012
FDA report date
Feb 13, 2013
Quantity
23,315 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Hospira Inc.

Original FDA data

Every field from FDA enforcement report D-153-2013, exactly as published.

Show all FDA fields
City
Lake Forest
State
IL
Status
Completed
Country
United States
Event ID
63548
Address
275 N Field Dr
Code information
Lot #: Z021650AA, Exp. 08/2013
Postal code
60045-2579
Report date
Feb 13, 2013
Product type
Drugs
Recall number
D-153-2013
Classification
Class I
Recalling firm
Hospira Inc.
Product quantity
23,315 vials
Termination date
Mar 20, 2017
Reason for recall
Crystallization: Product is being recalled due to visible particulates identified during a retain sample inspection. Findings have identified the particles as Carboplatin crystals.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Carboplatin Injection, 600 mg/60 mL (10 mg/mL), 60 mL, Cytotoxic Agent, Sterile, Multi-Dose Vial, Rx only, For IV Use, Hospira, Inc., Lake Forest, IL 60045, Product of Australia, NDC 61703-339-56.
Distribution pattern
Nationwide and Puerto Rico.
Recall initiation date
Nov 8, 2012
Initial firm notification
Letter
Center classification date
Feb 6, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-153-2013, published Feb 13, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls